Cardiac and gastric effects of histamine H-2 receptor antagonists: No evidence for a correlation between lipophilicity and receptor affinity

被引:11
作者
Coruzzi, G
Adami, M
Pozzoli, C
Giorgi, F
Bertaccini, G
机构
[1] UNIV PARMA,INST PHARMACOL,I-43100 PARMA,ITALY
[2] SIGMA TAU PHARMACEUT CO,DEPT CHEM RES,I-00040 POMEZIA,ITALY
关键词
histamine H-2 receptors; heart; stomach; aminopotentidine; iodoaminopotentidine; compound SK&F 92857; lipophilicity;
D O I
10.1111/j.1476-5381.1996.tb15608.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 A series of histamine H-2 receptor antagonists with different lipophilicity were tested in cardiac and gastric assays in order to reveal possible differences in receptor affinity. Lipophilicity of the compounds was expressed as CLOG P (theoretically-determined logarithm of octanol:water partition coefficient) and log k' (logarithm of capacity factor, experimentally-determined by reverse-phase high performance liquid chromatography). 2 Aminopotentidine (APT) and iodoaminopotentidine (I-APT), which are both lipophilic compounds, behaved as insurmountable antagonists of histamine responses in rat isolated gastric fundus (pK(B) = 6.20+/-0.16 and 6.89+/-0.19, respectively) and guinea-pig isolated papillary muscle (pK(B) = 6.34+/-0.37 and 6.81+/-0.26, respectively). They were approximately as effective as ranitidine (RAN) in reducing histamine-induced acid secretion in the anaesthetized rat, ID50 values being 0.018+/-0.02, 0.020+/-0.03 and 0.036+/-0.01 mu mol kg(-1) i.v. for APT, I-APT and RAN, respectively. Both APT and I-APT had a significantly longer duration of action than RAN. 3 The hydrophilic compound, SK&F 92857, was inactive up to 10 mu M in modifying histamine-induced acid secretion in the isolated rat stomach. In the papillary muscle, low concentrations (0.1-1 mu M) of this compound produced a competitive antagonism of the histamine responses (pA(2) value=7.38+/-0.11), while a higher concentration (10 mu M) significantly reduced the maximal response to histamine. 4 RAN competitively antagonized histamine effects with a comparable affinity in cardiac and gastric preparations (pA(2) values were 6.42+/-0.09 and 6.78+/-0.38 in heart and stomach, respectively). 5 Results obtained in this study clearly showed that the discrepancies between gastric and cardiac effects observed for some H-2 antagonists are not explained solely by differences in lipophilicity of compounds. Moreover, the significant correlation found between CLOG P and log k' parameter, which takes into account, besides their lipophilicity, the ionization of the molecules, suggests that ionization has a similar influence for all the molecules on the partition between the lipophilic and aqueous phase.
引用
收藏
页码:1813 / 1821
页数:9
相关论文
共 31 条
[1]  
ANGUS JA, 1979, BRIT J PHARMACOL, V67, P59
[2]   SOME QUANTITATIVE USES OF DRUG ANTAGONISTS [J].
ARUNLAKSHANA, O ;
SCHILD, HO .
BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1959, 14 (01) :48-58
[3]   EFFECT OF IMPROMIDINE (SK-AND-F-92676) ON THE ISOLATED PAPILLARY-MUSCLE OF THE GUINEA-PIG [J].
BERTACCINI, G ;
CORUZZI, G .
BRITISH JOURNAL OF PHARMACOLOGY, 1981, 72 (02) :197-199
[4]   FURTHER ANALYSIS OF ANOMALOUS PKB VALUES FOR HISTAMINE H-2-RECEPTOR ANTAGONISTS ON THE MOUSE ISOLATED STOMACH ASSAY [J].
BLACK, JW ;
LEFF, P ;
SHANKLEY, NP .
BRITISH JOURNAL OF PHARMACOLOGY, 1985, 86 (03) :581-587
[6]   SYNTHESIS AND HISTAMINE H-2-RECEPTOR ANTAGONIST ACTIVITY OF 4-(1-PYRAZOLYL)BUTANAMIDES, GUANIDINOPYRAZOLES, AND RELATED-COMPOUNDS [J].
BUSCHAUER, A ;
MOHR, R ;
SCHUNACK, W .
ARCHIV DER PHARMAZIE, 1995, 328 (04) :349-358
[7]   ZOLANTIDINE (SK-AND-F-95282) IS A POTENT SELECTIVE BRAIN-PENETRATING HISTAMINE H-2-RECEPTOR ANTAGONIST [J].
CALCUTT, CR ;
GANELLIN, CR ;
GRIFFITHS, R ;
LEIGH, BK ;
MAGUIRE, JP ;
MITCHELL, RC ;
MYLEK, ME ;
PARSONS, ME ;
SMITH, IR ;
YOUNG, RC .
BRITISH JOURNAL OF PHARMACOLOGY, 1988, 93 (01) :69-78
[8]  
Coruzzi G, 1995, Inflamm Res, V44 Suppl 1, pS108, DOI 10.1007/BF01674420
[9]   ACTION OF HISTAMINE AND OF SOME H-2-ANTAGONISTS ON GASTRIC-SECRETION INVITRO [J].
CORUZZI, G ;
ADAMI, M ;
BERTACCINI, G .
AGENTS AND ACTIONS, 1984, 14 (3-4) :516-521
[10]   ACTIVITY OF THE NEW HISTAMINE H-2-RECEPTOR ANTAGONIST ZOLANTIDINE AT CARDIAC AND GASTRIC H-2-RECEPTORS [J].
CORUZZI, G ;
ADAMI, M ;
POZZOLI, C ;
POLI, E ;
BERTACCINI, G .
PHARMACOLOGY, 1994, 48 (02) :69-76